AstraZeneca appoints Fante to head U.S.

Executive Summary

U.K drug maker names Rich Fante to U.S. President Nov. 13. Fante, a 13-year veteran of the firm, was most recently VP-brand strategy and portfolio operations, leading development and marketing for all AstraZeneca brands in the U.S. Fante takes the helm from Tony Zook, CEO of North America and head of global marketing, whose role was expanded in July to include oversight of MedImmune after CEO David Mott left the firm one year after AstraZeneca's $15.6 billion buyout (1"The Pink Sheet" DAILY, June 26, 2008)